scholarly journals The relationship of sit-to-stand tests with 6-minute walk test in healthy young adults

Medicine ◽  
2018 ◽  
Vol 97 (1) ◽  
pp. e9489 ◽  
Author(s):  
Hulya Nilgun Gurses ◽  
Melih Zeren ◽  
Hilal Denizoglu Kulli ◽  
Elif Durgut
2021 ◽  
Vol 12 (2) ◽  
pp. 470-477
Author(s):  
Safa Liyaqatali Honpode ◽  
Reema Shankar Rajam ◽  
Bhavana Suhas Mhatre ◽  
Snehal Sunil Sawant ◽  
Vibhawari Manoj Wagh ◽  
...  

Background: Coronavirus disease (COVID-19) is an infectious disease, causing a range of symptoms such as fever, cough, and dyspnea. 6 Minute walk test (6MWT) is recommended to measure functional capacity in COVID-19. 1- Min sit to stand (STS-1) test has been used as its alternative in various respiratory conditions. This retrospective study aims to explore the relationship between the two tests in patients with COVID-19. Patients and methods: The medical records of COVID-19 patients in a male step down unit, referred for physical therapy between the periods from 5th September, 2020 to 25th September, 2020 were analysed retrospectively. Hemodynamically stable patients who underwent 6MWT and STS-1 prior to discharge, were included in the analysis. SPSS Version 24 was used to find the correlation between 6-min walk distance (6MWD) and number of repetitions in STS-1; and to compare the haemodynamic responses between the two tests. Results: There was a statistically significant positive correlation between the 6MWD and the STS⁻¹ repetitions (r=0.75, p<0.0001). On comparison of the two tests, the change in heart rate (HR) was significantly greater in the STS⁻¹ (p = 0.027). Whereas, the change in dyspnea (modified Borg’s score) and SpO2 was similar in both the groups and was not statistically significant (p= 0.10, p=0.62; respectively). Conclusion: There is a significant correlation between the 6MWT and STS⁻¹ test with similar haemodynamic response and can perhaps be used as an alternative to 6MWT in COVID-19.


2021 ◽  
pp. 135910532110092
Author(s):  
Dylan G Serpas ◽  
Laura Zettel-Watson ◽  
Barbara J Cherry

This study investigated the mediating role of depressive symptoms among 147 middle-aged and older adults with FM in the relationship between pain intensity and 4 objective measures of physical performance: Fullerton Advanced Balance scale (FAB), 6-Minute Walk Test (6MWT), 30-Second Chair Stand (30SCS), and 8-Foot Up and Go Test (8FUPGT). Asymptotic mediation analyses revealed that depressive symptoms fully mediated the relationship between pain intensity and FAB (95% CI [−0.40, −0.10]) and 8FUPGT (CI [0.02, 0.11]) and partially mediated the relationship to 6MWT (CI [−9.15, −2.20]) and 30SCS (CI [−0.29, −0.06]). Findings support the evaluation of co-morbid depression in FM.


2021 ◽  
Vol 25 (3 (99)) ◽  
pp. 138-143
Author(s):  
O. Khaniukov ◽  
O. Smolianova

The purpose of the work. To identify the factors that determine the relationship between adherence to treatment and QoL in the elderly with CHF on the background of AH and CKD, and to assess the possibilities of using the obtained data in clinical practice.Material and methods. The study included 93 patients from 60 to 74 years old with CHF on the background of AH and CKD. Clinical and laboratory studies, a questionnaire regarding the presence of side effects, an assessment of the quality of life using the Minnesota questionnaire and adherence to treatment according to the Morisky-Green scale were used in all the patients.Results. Correlation analysis revealed the following relationships: for adherence to QoL - -0.57 (-0.69; -0.42); for systolic blood pressure with QoL - 0.46 (0.28; 0.61) and with adherence - -0.35 (-0.52; -0.16;); for the creatinine with QоL - 0.35 (0.16; 0.52) and with adherence - -0.3 (- 0.47; -0.1); for EPI GFR with QoL - -0.46 (-0.61; -0.28) and with adherence - 0.33 (0.14; 0.5); for the 6-minute walk test with QoL - -0.65 (-0.78; -0.52) and with adherence - 0.49 (0.32; 0.63). For all identified relationships p is <0.05.Conclusions. In the elderly with CHF on the background of AH and CKD, correlations of moderate strength were found between the clinical and laboratory parameters of these diseases, QoL, and adherence to treatment. Identified pathogenetic links can be used to explain to the patient the need to follow the doctor's recommendations. A change in QoL can serve as a marker showing that some revising is needed in a patients’ treatment.


Sign in / Sign up

Export Citation Format

Share Document